COVID-19 Pandemic Causing Delays in Breast Cancer Care

 A high proportion of patients with breast cancer report significant delays in cancer care and treatment during the COVID-19 pandemic, according to the results of a patient survey now published in Breast Cancer Research and Treatment. As the pandemic continues to evolve, the majority of new cancer care guidelines have focused on minimizing the risk of spreading COVID-19 without compromising the outcomes of patients with cancer. However, because delays or interruptions in treatment can negat...
Continue reading

Cancer Overscreening in Older Adults: Jennifer L. Moss, PhD

According to a study recently published in JAMA Network Open, a high proportion of older adults with average cancer risk are overscreened for colorectal, cervical, and breast cancers after surpassing specified upper age limits recommended by the US Preventive Services Task Force (USPSTF). In this interview, Jennifer L. Moss, PhD, first author of the study, discusses the significance of these findings, explains the risks of overscreening, and shares advice for reducing overscreening among older a...
Continue reading

Thanks to COVID, New Cancer Diagnoses Fell by Nearly Half

During the COVID-19 pandemic, guidelines from the American Society of Clinical Oncology and other organizations have recommended that cancer screening procedures involving in-person visits, such as mammograms and colonoscopies, be postponed. These delays have contributed to a whopping 46.4% drop in the combined rate of new diagnoses for six cancers. This is the finding of a cross-sectional study, results of which have now been published in a research letter in JAMA Network Open, a...
Continue reading

Breast Cancer Chemotherapy in Older Patients With Comorbidities: Nina Tamirisa, MD

Many older patients with breast cancer have significant comorbidities, increasing the challenges of treatment. These challenges are compounded by the fact that elderly patients with multiple comorbidities are frequently excluded from participating in clinical trials, resulting in a lack of treatment data for this population. Nina Tamirisa, MD, and colleagues recently published a study in JAMA Oncology reporting that in older patients with multiple comorbidities and estrogen receptor–positive, no...
Continue reading

Cancer Overscreening High Among Older Adults

Overscreening for colorectal, cervical, and breast cancer is prevalent among older adults in the United States, according to the results of a new study. While routine cancer screening for adults with average cancer risk is recommended by the US Preventive Services Task Force (USPSTF), it is recommended that screening be discontinued once individuals reach a specified upper age limit, defined as age 75 for colorectal cancer, age 65 for cervical cancer, and age 74 for breast cancer. However, many ...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.